Open access publisher BioMed Central, UK, has announced that its journal Experimental Hematology & Oncology is now accepting submissions. The journal will make a deliberate effort in publishing clinical trials with ‘negative’ results and basic science studies with provocative findings.
The journal aims to publish original work, hypothesis, commentaries and timely reviews in the field of hematology and oncology. With open access, rapid turnaround time from submission to publication and online live comments from readers, Experimental Hematology & Oncology strives to be the hub for disseminating new knowledge and discussing controversial topics for both basic scientists and busy clinicians in the field of hematology and oncology.
Hematology and oncology are closely related and rapidly changing fields. The journal acts as an international platform for sharing laboratory findings in these areas.
Search for more Oncology related STM journals
New Release - Journals/Products/Services
More News in this Theme